Guangdong Zhongsheng Pharmaceutical 众生药业
4 significant filings since 31 May 2026: 2 on guarantee or financial assistance, 1 on acquisition or disposal and 1 on equity incentive. The latest, on 22 Sep 2026: 关于公司为合并报表范围内子公司提供担保的进展公告.
自 31 May 2026 起有 4 份重大公告：guarantee or financial assistance 2 份、acquisition or disposal 1 份、equity incentive 1 份。最新一份（22 Sep 2026）：关于公司为合并报表范围内子公司提供担保的进展公告。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 0.41 | 0.47 |
| 7 days ago | 0.40 | 0.47 |
| 30 days ago | 0.40 | 0.47 |
| 60 days ago | 0.40 | 0.47 |
| 90 days ago | 0.40 | 0.47 |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from 0.46 in Jul 2025 to 0.41 in Sep 2026 (-10.9%). 一致预期从 Jul 2025 的 0.46 变为 Sep 2026 的 0.41 (-10.9%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 1 | ▲ 0 ▼ 0 = 1 |
| Last 90 days | ▲ 0 ▼ 1 = 1 | ▲ 0 ▼ 1 = 1 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
| Year | Filed | Consensus | Brokers 券商 | Reported 实际 | Surprise 偏差 |
|---|---|---|---|---|---|
| FY2025 | 29 Apr 2026 | 0.36 | 3 | 0.33 | -8.3% |
Surprise is reported EPS against the consensus on the day before the annual report was filed. 偏差为实际每股收益与年报披露前一日一致预期之差。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2024 had 0. 惊喜幅度需公告前120天内至少3家券商预测；FY2024仅0家。